- Home
- ASIX vs LENZ Comparison
ASIX vs LENZ Comparison
Compare ASIX & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASIX
- LENZ
- Stock Information
- Founded
- ASIX 2016
- LENZ 2019
- Country
- ASIX United States
- LENZ United States
- Employees
- ASIX N/A
- LENZ N/A
- Industry
- ASIX Major Chemicals
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- ASIX Industrials
- LENZ Health Care
- Exchange
- ASIX Nasdaq
- LENZ Nasdaq
- Market Cap
- ASIX 727.4M
- LENZ 614.9M
- IPO Year
- ASIX N/A
- LENZ 2021
- Fundamental
- Price
- ASIX $31.87
- LENZ $23.82
- Analyst Decision
- ASIX Strong Buy
- LENZ Strong Buy
- Analyst Count
- ASIX 2
- LENZ 6
- Target Price
- ASIX $39.50
- LENZ $35.40
- AVG Volume (30 Days)
- ASIX 142.1K
- LENZ 197.6K
- Earning Date
- ASIX 02-21-2025
- LENZ 11-06-2024
- Dividend Yield
- ASIX 2.02%
- LENZ 30.67%
- EPS Growth
- ASIX N/A
- LENZ N/A
- EPS
- ASIX 1.42
- LENZ N/A
- Revenue
- ASIX $1,570,703,000.00
- LENZ N/A
- Revenue This Year
- ASIX $3.94
- LENZ N/A
- Revenue Next Year
- ASIX $7.65
- LENZ N/A
- P/E Ratio
- ASIX $22.28
- LENZ N/A
- Revenue Growth
- ASIX 0.98
- LENZ N/A
- 52 Week Low
- ASIX $20.86
- LENZ $2.57
- 52 Week High
- ASIX $33.00
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- ASIX 65.95
- LENZ 35.08
- Support Level
- ASIX $26.16
- LENZ $21.34
- Resistance Level
- ASIX $28.46
- LENZ $23.84
- Average True Range (ATR)
- ASIX 0.94
- LENZ 1.58
- MACD
- ASIX 0.55
- LENZ -0.39
- Stochastic Oscillator
- ASIX 92.39
- LENZ 25.78
About ASIX AdvanSix Inc.
AdvanSix Inc. is an integrated manufacturer of Nylon 6, a polymer resin and fertilizers. Nylon 6 is a synthetic material used by customers to produce engineered plastics, fibers, filaments, and films, which in turn are used in such end-products as automotive and electronic components, carpets, sports apparel, fishing nets, and food and industrial packaging. In addition, it also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process including caprolactam, ammonium sulfate fertilizers, and other chemical intermediates. Geographically, the group operates through the United States and its business is also expanding internationally but it derives the majority of its revenue from the United States region.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.